{"count": 321, "results": [{"_id": "37492087", "pmid": 37492087, "pmcid": "PMC10363978", "title": "Efficacy and safety of Qiangli Dingxuan tablet combined with amlodipine besylate for essential hypertension: a randomized, double-blind, placebo-controlled, parallel-group, multicenter trial", "journal": "Front Pharmacol", "authors": ["Lin J", "Wang Q", "Zhong D", "Zhang J", "Yuan T", "Wu H", "Li B", "Li S", "Xie X", "An D", "Deng Y", "Xian S", "Xiong X", "Yao K"], "date": "2023-07-10T00:00:00Z", "doi": "10.3389/fphar.2023.1225529", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1225529", "score": 50309.207, "text_hl": "Efficacy and safety of Qiangli Dingxuan tablet combined with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine besylate@@@ for @<m>DISEASE_Essential_Hypertension</m> @DISEASE_MESH:D000075222 @@@essential hypertension@@@: a randomized, double-blind, placebo-controlled, parallel-group, multicenter trial", "citations": {"NLM": "Lin J, Wang Q, Zhong D, Zhang J, Yuan T, Wu H, Li B, Li S, Xie X, An D, Deng Y, Xian S, Xiong X, Yao K. Efficacy and safety of Qiangli Dingxuan tablet combined with amlodipine besylate for essential hypertension: a randomized, double-blind, placebo-controlled, parallel-group, multicenter trial Front Pharmacol. 2023;14():1225529. PMID: 37492087", "BibTeX": "@article{37492087, title={Efficacy and safety of Qiangli Dingxuan tablet combined with amlodipine besylate for essential hypertension: a randomized, double-blind, placebo-controlled, parallel-group, multicenter trial}, author={Lin J and Wang Q and Zhong D and Zhang J and Yuan T and Wu H and Li B and Li S and Xie X and An D and Deng Y and Xian S and Xiong X and Yao K}, journal={Front Pharmacol}, volume={14}, pages={1225529}}"}}, {"_id": "32901435", "pmid": 32901435, "pmcid": "PMC7581658", "title": "Effectiveness of Amlodipine on Blood Pressure Control in Hypertensive Patients in India: A Real-World, Retrospective Study from Electronic Medical Records", "journal": "Drugs Real World Outcomes", "authors": ["Khan MY", "Pandit S", "Ray S", "Mohan JC", "Srinivas BC", "Ramakrishnan S", "Mane A", "Mehta S", "Shah S"], "date": "2020-12-01T00:00:00Z", "doi": "10.1007/s40801-020-00211-w", "meta_date_publication": "2020 Dec", "meta_volume": "7", "meta_issue": "4", "meta_pages": "281-293", "score": 50307.406, "text_hl": "To provide real-world evidence regarding the effectiveness of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ as monotherapy or in combination with other antihypertensive drugs (AHDs) in Indian @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Essential_Hypertension</m> @DISEASE_MESH:D000075222 @@@essential hypertension@@@.", "citations": {"NLM": "Khan MY, Pandit S, Ray S, Mohan JC, Srinivas BC, Ramakrishnan S, Mane A, Mehta S, Shah S. Effectiveness of Amlodipine on Blood Pressure Control in Hypertensive Patients in India: A Real-World, Retrospective Study from Electronic Medical Records Drugs Real World Outcomes. 2020 Dec;7(4):281-293. PMID: 32901435", "BibTeX": "@article{32901435, title={Effectiveness of Amlodipine on Blood Pressure Control in Hypertensive Patients in India: A Real-World, Retrospective Study from Electronic Medical Records}, author={Khan MY and Pandit S and Ray S and Mohan JC and Srinivas BC and Ramakrishnan S and Mane A and Mehta S and Shah S}, journal={Drugs Real World Outcomes}, volume={7}, number={4}, pages={281-293}}"}}, {"_id": "35188327", "pmid": 35188327, "pmcid": "PMC8925000", "title": "Ambulatory blood pressure response to S-amlodipine in Korean adult patients with uncontrolled essential hypertension: A prospective, observational study", "journal": "J Clin Hypertens (Greenwich)", "authors": ["Kim DK", "Ahn JH", "Lee KH", "Kang SH", "Kim SS", "Na JO", "Park SD", "Ahn KT", "Lee JH", "Jung IH", "Seo J", "Choi WG"], "date": "2022-03-01T00:00:00Z", "doi": "10.1111/jch.14442", "meta_date_publication": "2022 Mar", "meta_volume": "24", "meta_issue": "3", "meta_pages": "350-357", "score": 50302.44, "text_hl": "In conclusion, this study demonstrated the efficacy and safety of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@S-amlodipine@@@ in @SPECIES_9606 @@@patients@@@ with uncontrolled @<m>DISEASE_Essential_Hypertension</m> @DISEASE_MESH:D000075222 @@@essential hypertension@@@.", "citations": {"NLM": "Kim DK, Ahn JH, Lee KH, Kang SH, Kim SS, Na JO, Park SD, Ahn KT, Lee JH, Jung IH, Seo J, Choi WG. Ambulatory blood pressure response to S-amlodipine in Korean adult patients with uncontrolled essential hypertension: A prospective, observational study J Clin Hypertens (Greenwich). 2022 Mar;24(3):350-357. PMID: 35188327", "BibTeX": "@article{35188327, title={Ambulatory blood pressure response to S-amlodipine in Korean adult patients with uncontrolled essential hypertension: A prospective, observational study}, author={Kim DK and Ahn JH and Lee KH and Kang SH and Kim SS and Na JO and Park SD and Ahn KT and Lee JH and Jung IH and Seo J and Choi WG}, journal={J Clin Hypertens (Greenwich)}, volume={24}, number={3}, pages={350-357}}"}}, {"_id": "35227313", "pmid": 35227313, "pmcid": "PMC8886760", "title": "Effect of a fixed-dose combination of Telmisartan/S-amlodipine on circadian blood pressure compared with Telmisartan monotherapy: TENUVA-BP study", "journal": "Clin Hypertens", "authors": ["Kim BJ", "Cho KI", "Kwon HM", "Choi SM", "Yoon CH", "Lim SW", "Joo SJ", "Lee NH", "Lim SY", "Lim SH", "Kim HS"], "date": "2022-03-01T00:00:00Z", "doi": "10.1186/s40885-021-00184-0", "meta_date_publication": "2022 Mar 1", "meta_volume": "28", "meta_issue": "1", "meta_pages": "7", "score": 50293.36, "text_hl": "This study evaluated the circadian efficacy of a @CHEMICAL_Telmisartan @CHEMICAL_MESH:D000077333 @@@telmisartan@@@ 40 mg/S-@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ 2.5 mg fixed-dose combination (Telmisartan40/@CHEMICAL_Sulfur @CHEMICAL_MESH:D013455 @@@S-@@@Amlodipine2.5) compared to @CHEMICAL_Telmisartan @CHEMICAL_MESH:D000077333 @@@telmisartan@@@ 80 mg (Telmisartan80) in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Essential_Hypertension</m> @DISEASE_MESH:D000075222 @@@essential hypertension@@@ who did not respond to 2-4 weeks' treatment with @CHEMICAL_Telmisartan @CHEMICAL_MESH:D000077333 @@@telmisartan@@@ 40 mg.", "citations": {"NLM": "Kim BJ, Cho KI, Kwon HM, Choi SM, Yoon CH, Lim SW, Joo SJ, Lee NH, Lim SY, Lim SH, Kim HS. Effect of a fixed-dose combination of Telmisartan/S-amlodipine on circadian blood pressure compared with Telmisartan monotherapy: TENUVA-BP study Clin Hypertens. 2022 Mar 1;28(1):7. PMID: 35227313", "BibTeX": "@article{35227313, title={Effect of a fixed-dose combination of Telmisartan/S-amlodipine on circadian blood pressure compared with Telmisartan monotherapy: TENUVA-BP study}, author={Kim BJ and Cho KI and Kwon HM and Choi SM and Yoon CH and Lim SW and Joo SJ and Lee NH and Lim SY and Lim SH and Kim HS}, journal={Clin Hypertens}, volume={28}, number={1}, pages={7}}"}}, {"_id": "37255900", "pmid": 37255900, "pmcid": "PMC10225746", "title": "Effectiveness of Amlodipine in the Control of 24-Hour Blood Pressure in Mild-to-Moderate Essential Hypertension: A Prospective, Multicenter, Observational Real-World Study from India", "journal": "Cureus", "authors": ["D P", "Guha S", "Rathod R", "Gaurav K"], "date": "2023-04-28T00:00:00Z", "doi": "10.7759/cureus.38272", "meta_date_publication": "2023 Apr", "meta_volume": "15", "meta_issue": "4", "meta_pages": "e38272", "score": 50287.4, "text_hl": "Effectiveness of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ in the Control of 24-Hour Blood Pressure in Mild-to-Moderate @<m>DISEASE_Essential_Hypertension</m> @DISEASE_MESH:D000075222 @@@Essential Hypertension@@@: A Prospective, Multicenter, Observational Real-World Study from India", "citations": {"NLM": "D P, Guha S, Rathod R, Gaurav K. Effectiveness of Amlodipine in the Control of 24-Hour Blood Pressure in Mild-to-Moderate Essential Hypertension: A Prospective, Multicenter, Observational Real-World Study from India Cureus. 2023 Apr;15(4):e38272. PMID: 37255900", "BibTeX": "@article{37255900, title={Effectiveness of Amlodipine in the Control of 24-Hour Blood Pressure in Mild-to-Moderate Essential Hypertension: A Prospective, Multicenter, Observational Real-World Study from India}, author={D P and Guha S and Rathod R and Gaurav K}, journal={Cureus}, volume={15}, number={4}, pages={e38272}}"}}, {"_id": "35251710", "pmid": 35251710, "pmcid": "PMC8890895", "title": "A Retrospective, Observational, EMR-Based Real-World Evidence Study to Assess the Incidence of Pedal Edema in Essential Hypertensive Patients on Amlodipine or Cilnidipine", "journal": "Int J Hypertens", "authors": ["Dalal J", "Sawhney JP", "Jayagopal PB", "Hazra PK", "Khan MY", "Gaurav K", "Pinto C", "Mane A", "Rao S", "Jain M"], "date": "2022-02-23T00:00:00Z", "doi": "10.1155/2022/6868143", "meta_date_publication": "2022", "meta_volume": "2022", "meta_issue": "", "meta_pages": "6868143", "score": 50285.832, "text_hl": "...@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ is one of the most preferred drugs of choice for @<m>DISEASE_Essential_Hypertension</m> @DISEASE_MESH:D000075222 @@@essential hypertension@@@ amongst the CCBs. ", "citations": {"NLM": "Dalal J, Sawhney JP, Jayagopal PB, Hazra PK, Khan MY, Gaurav K, Pinto C, Mane A, Rao S, Jain M. A Retrospective, Observational, EMR-Based Real-World Evidence Study to Assess the Incidence of Pedal Edema in Essential Hypertensive Patients on Amlodipine or Cilnidipine Int J Hypertens. 2022;2022():6868143. PMID: 35251710", "BibTeX": "@article{35251710, title={A Retrospective, Observational, EMR-Based Real-World Evidence Study to Assess the Incidence of Pedal Edema in Essential Hypertensive Patients on Amlodipine or Cilnidipine}, author={Dalal J and Sawhney JP and Jayagopal PB and Hazra PK and Khan MY and Gaurav K and Pinto C and Mane A and Rao S and Jain M}, journal={Int J Hypertens}, volume={2022}, pages={6868143}}"}}, {"_id": "34115326", "pmid": 34115326, "pmcid": "PMC8555025", "title": "Effectiveness and Effect on Renal Parameters of Amlodipine vs. Other Dihydropyridine Calcium Channel Blockers in Patients with Essential Hypertension: Retrospective Observational Study Based on Real-World Evidence from Electronic Medical Records", "journal": "Cardiol Ther", "authors": ["Jadhav U", "Mohanan PP", "Almeida AF", "Abraham G", "Khan MY", "Gaurav K", "Mane A", "Vikas S", "Jain M", "Meel B"], "date": "2021-12-01T00:00:00Z", "doi": "10.1007/s40119-021-00224-8", "meta_date_publication": "2021 Dec", "meta_volume": "10", "meta_issue": "2", "meta_pages": "465-480", "score": 50284.746, "text_hl": "Effectiveness and Effect on Renal Parameters of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ vs. Other @CHEMICAL_1_4_dihydropyridine @CHEMICAL_MESH:C038806 @@@Dihydropyridine@@@ Calcium Channel Blockers in @SPECIES_9606 @@@Patients@@@ with @<m>DISEASE_Essential_Hypertension</m> @DISEASE_MESH:D000075222 @@@Essential Hypertension@@@: Retrospective Observational Study Based on Real-World Evidence from Electronic Medical Records", "citations": {"NLM": "Jadhav U, Mohanan PP, Almeida AF, Abraham G, Khan MY, Gaurav K, Mane A, Vikas S, Jain M, Meel B. Effectiveness and Effect on Renal Parameters of Amlodipine vs. Other Dihydropyridine Calcium Channel Blockers in Patients with Essential Hypertension: Retrospective Observational Study Based on Real-World Evidence from Electronic Medical Records Cardiol Ther. 2021 Dec;10(2):465-480. PMID: 34115326", "BibTeX": "@article{34115326, title={Effectiveness and Effect on Renal Parameters of Amlodipine vs. Other Dihydropyridine Calcium Channel Blockers in Patients with Essential Hypertension: Retrospective Observational Study Based on Real-World Evidence from Electronic Medical Records}, author={Jadhav U and Mohanan PP and Almeida AF and Abraham G and Khan MY and Gaurav K and Mane A and Vikas S and Jain M and Meel B}, journal={Cardiol Ther}, volume={10}, number={2}, pages={465-480}}"}}, {"_id": "32267481", "pmid": 32267481, "title": "Comparison of Blood Pressure Variability Between Losartan and Amlodipine in Essential Hypertension (COMPAS-BPV).", "journal": "Am J Hypertens", "authors": ["Lee JW", "Choi E", "Son JW", "Youn YJ", "Ahn SG", "Ahn MS", "Kim JY", "Lee SH", "Yoon J", "Ryu DR", "Park SM", "Hong KS", "Yoo BS"], "date": "2020-08-04T00:00:00Z", "doi": "10.1093/ajh/hpaa060", "meta_date_publication": "2020 Aug 4", "meta_volume": "33", "meta_issue": "8", "meta_pages": "748-755", "score": 50272.273, "text_hl": "Comparison of Blood Pressure Variability Between @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@Losartan@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ in @<m>DISEASE_Essential_Hypertension</m> @DISEASE_MESH:D000075222 @@@Essential Hypertension@@@ (COMPAS-BPV).", "citations": {"NLM": "Lee JW, Choi E, Son JW, Youn YJ, Ahn SG, Ahn MS, Kim JY, Lee SH, Yoon J, Ryu DR, Park SM, Hong KS, Yoo BS. Comparison of Blood Pressure Variability Between Losartan and Amlodipine in Essential Hypertension (COMPAS-BPV). Am J Hypertens. 2020 Aug 4;33(8):748-755. PMID: 32267481", "BibTeX": "@article{32267481, title={Comparison of Blood Pressure Variability Between Losartan and Amlodipine in Essential Hypertension (COMPAS-BPV).}, author={Lee JW and Choi E and Son JW and Youn YJ and Ahn SG and Ahn MS and Kim JY and Lee SH and Yoon J and Ryu DR and Park SM and Hong KS and Yoo BS}, journal={Am J Hypertens}, volume={33}, number={8}, pages={748-755}}"}}, {"_id": "38557512", "pmid": 38557512, "title": "Comparative Efficacy and Safety of Amlodipine and Losartan Potassium in Essential Hypertension in a Tertiary Hospital of Bangladesh.", "journal": "Mymensingh Med J", "authors": ["Shimu RN", "Majumder S", "Tarannum F", "Chowdhury DP", "Nahar A", "Afrin A", "Akter M", "Nahar S", "Jahan S", "Hossain MA"], "date": "2024-04-01T00:00:00Z", "meta_date_publication": "2024 Apr", "meta_volume": "33", "meta_issue": "2", "meta_pages": "365-372", "score": 50270.22, "text_hl": "Comparative Efficacy and Safety of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ and @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@Losartan Potassium@@@ in @<m>DISEASE_Essential_Hypertension</m> @DISEASE_MESH:D000075222 @@@Essential Hypertension@@@ in a Tertiary Hospital of Bangladesh.", "citations": {"NLM": "Shimu RN, Majumder S, Tarannum F, Chowdhury DP, Nahar A, Afrin A, Akter M, Nahar S, Jahan S, Hossain MA. Comparative Efficacy and Safety of Amlodipine and Losartan Potassium in Essential Hypertension in a Tertiary Hospital of Bangladesh. Mymensingh Med J. 2024 Apr;33(2):365-372. PMID: 38557512", "BibTeX": "@article{38557512, title={Comparative Efficacy and Safety of Amlodipine and Losartan Potassium in Essential Hypertension in a Tertiary Hospital of Bangladesh.}, author={Shimu RN and Majumder S and Tarannum F and Chowdhury DP and Nahar A and Afrin A and Akter M and Nahar S and Jahan S and Hossain MA}, journal={Mymensingh Med J}, volume={33}, number={2}, pages={365-372}}"}}, {"_id": "36737518", "pmid": 36737518, "title": "Effects of olmesartan and amlodipine on blood pressure, endothelial function, and vascular inflammation.", "journal": "J Nucl Cardiol", "authors": ["Honda A", "Tahara N", "Tahara A", "Bekki M", "Maeda-Ogata S", "Sugiyama Y", "Igata S", "Nishino Y", "Matsui T", "Kurata S", "Abe T", "Yamagishi SI", "Fukumoto Y"], "date": "2023-02-03T00:00:00Z", "doi": "10.1007/s12350-023-03200-y", "meta_date_publication": "2023 Feb 3", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50265.613, "text_hl": "METHODS: Forty-five @SPECIES_9606 @@@patients@@@ (mean age 58.5 +- 11.2 years) with uncontrolled @<m>DISEASE_Essential_Hypertension</m> @DISEASE_MESH:D000075222 @@@essential hypertension@@@ were randomly assigned to receive @CHEMICAL_olmesartan @CHEMICAL_MESH:C437965 @@@olmesartan@@@, an angiotensin II type 1 receptor blocker (ARB) (N = 23), or @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@, a calcium channel blocker (CCB) (N = 22), for 6 months. ", "citations": {"NLM": "Honda A, Tahara N, Tahara A, Bekki M, Maeda-Ogata S, Sugiyama Y, Igata S, Nishino Y, Matsui T, Kurata S, Abe T, Yamagishi SI, Fukumoto Y. Effects of olmesartan and amlodipine on blood pressure, endothelial function, and vascular inflammation. J Nucl Cardiol. 2023 Feb 3;():. PMID: 36737518", "BibTeX": "@article{36737518, title={Effects of olmesartan and amlodipine on blood pressure, endothelial function, and vascular inflammation.}, author={Honda A and Tahara N and Tahara A and Bekki M and Maeda-Ogata S and Sugiyama Y and Igata S and Nishino Y and Matsui T and Kurata S and Abe T and Yamagishi SI and Fukumoto Y}, journal={J Nucl Cardiol}}"}}]}